Study the effect of Probiotics on Neonatal Jaundice Preventio

Phase 3

• Conditions: eonatal jaundice.; Neonatal jaundice, unspecified; P59.9

• Registration Number: IRCT20130308012743N2
• Lead Sponsor: Mashhad University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 5 November 2019

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

Infants with pregnancy age greater than 37 weeks
Birth weight is more than 2500 grams
Parental Satisfaction

Exclusion Criteria

risk factor for jaundice

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Amount of bilirubin. Timepoint: Before the intervention and 3 and 5 days after taking the probiotic capsule. Method of measurement: Skin bilirubinometer.